Health In Tech director granted 13,598 shares

Shrestha Sanjay K reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Shrestha Sanjay K reported acquisition or exercise transactions in this Form 4 filing.

Health In Tech, Inc. director Sanjay K. Shrestha received a grant of 13,598 restricted shares of Class A Common Stock, valued at $1.36 per share, as compensation under the Health in Tech Equity Incentive Plan. The restricted stock vested on the grant date, bringing his direct holdings to 82,333 shares.

Insider Trade Summary

Grant/Award: 13,598 shares

Grant/Award 1 txn

Insider Shrestha Sanjay K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	13,598	$1.36	$18K

Holdings After Transaction: Class A Common Stock — 82,333 shares (Direct)

Footnotes (1)

1. F1. Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

Key Figures

Restricted shares granted: 13,598 shares Grant value per share: $1.36 per share Shares owned after grant: 82,333 shares

3 metrics

Restricted shares granted 13,598 shares Equity grant of Class A Common Stock

Grant value per share $1.36 per share Reporting price for restricted stock award

Shares owned after grant 82,333 shares Total direct Class A holdings post-transaction

Key Terms

restricted shares, Health in Tech Equity Incentive Plan, Class A Common Stock

3 terms

restricted shares financial

"Represents restricted shares of Class A Common Stock granted to the reporting person"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Health in Tech Equity Incentive Plan financial

"granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan"

Class A Common Stock financial

"Represents restricted shares of Class A Common Stock granted to the reporting person"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Health In Tech (HIT) director Sanjay K. Shrestha receive in this Form 4?

Director Sanjay K. Shrestha received a grant of 13,598 restricted shares of Health In Tech Class A Common Stock. These shares were issued as compensation under the company’s Equity Incentive Plan and vested immediately on the grant date, increasing his direct ownership stake.

Was the Health In Tech (HIT) Form 4 transaction an open-market stock purchase?

No, the Form 4 shows a grant of restricted shares, not an open-market purchase. The 13,598 shares were awarded as equity compensation under the Health in Tech Equity Incentive Plan and vested as of the grant date, rather than being bought in the market.

How many Health In Tech (HIT) shares does the director hold after this grant?

After the grant, director Sanjay K. Shrestha directly holds 82,333 shares of Health In Tech Class A Common Stock. This figure reflects his total direct ownership immediately following the 13,598-share restricted stock award reported in the Form 4 filing.

What is the value per share of the Health In Tech (HIT) restricted stock grant?

The restricted shares were valued at $1.36 per share for reporting purposes in the Form 4. This price is used to calculate the value of the 13,598-share equity award granted to director Sanjay K. Shrestha under the Health in Tech Equity Incentive Plan.

What plan governed the restricted stock grant reported for Health In Tech (HIT)?

The restricted stock grant was made under the Health in Tech Equity Incentive Plan. According to the footnote, the 13,598 restricted shares of Class A Common Stock were granted pursuant to this plan and fully vested as of the grant date disclosed in the Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/10/2026 - 08:42 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shrestha Sanjay K

(Last) (First) (Middle)

701 S. COLORADO AVE

SUITE 1

(Street)

STUART FLORIDA 34994

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	04/08/2026		A		13,598(1)	A	$1.36	82,333	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vested as of their grant date.

	/s/ Sanjay Shrestha	04/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)